Discovery and Optimization of Selective Nav1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain
- PMID: 26101568
- PMCID: PMC4468395
- DOI: 10.1021/acsmedchemlett.5b00059
Discovery and Optimization of Selective Nav1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain
Abstract
Voltage-gated sodium channels, in particular Nav1.8, can be targeted for the treatment of neuropathic and inflammatory pain. Herein, we described the optimization of Nav1.8 modulator series to deliver subtype selective, state, and use-dependent chemical matter that is efficacious in preclinical models of neuropathic and inflammatory pain.
Keywords: Nav1.8; SCN10A; TTX-R; Voltage-gated sodium channels; sodium channel drugs.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- Lampert A.; Eberhardt M.; Waxman Stephen G. Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents. Handb. Exp. Pharmacol. 2014, 221, 91–110. - PubMed
-
- Dib-Hajj S. D.; Cummins T. R.; Black J. A.; Waxman S. G. Sodium channels in normal and pathological pain. Annu. Rev. Neurosci. 2010, 33, 325–347. - PubMed
-
- Amaya F.; Decosterd I.; Samad T. A.; Plumpton C.; Tate S.; Mannion R. J.; Costigan M.; Woolf C. J. Diversity of expression of the sensory neuron-specific TTX-resistant voltage-gated sodium ion channels SNS and SNS2. Mol. Cell. Neurosci. 2000, 15, 331–342. - PubMed
-
- Shields S. D.; Ahn H.-S.; Yang Y.; Han C.; Seal R. P.; Wood J. N.; Waxman S. G.; Dib-Hajj S. D. Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system. Pain 2012, 153, 2017–2030. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
